Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 27
Filtrer
1.
PeerJ ; 12: e17137, 2024.
Article de Anglais | MEDLINE | ID: mdl-38529310

RÉSUMÉ

Gleditsia sinensis, commonly known as Chinese Zaojiao, has important economic value and medicinal compounds in its fruits and thorns, making it widely cultivated artificially in China. However, the available literature on the impact of waterlogging on the growth of G. sinensis seedlings and the accumulation of metabolite compounds in its thorns is limited. To address this knowledge gap, G. sinensis seedlings were planted in soil supplemented with pindstrup substrate, which enhances the water-holding capacity of the soil. The analyses of morphological traits and nutrient elements in one-year-old G. sinensis seedlings grown naturally under ambient conditions and metabolite accumulation in its thorns were conducted. The results showed that the waterlogged soil significantly diminished the height, fresh weight, and dry weight of seedling roots and stems (P < 0.05). Furthermore, waterlogging hindered the uptake of iron (Fe) and manganese (Mn), as well as the transport of potassium (K). The identified metabolites within the thorns were categorized into 16 distinct groups. Relative to the control soil, fatty acids and derivatives were the most down-regulated metabolites in the waterlogged soil, accounting for 40.58% of the total metabolites, followed by lignans (38.71%), phenolic acids (34.48%), saccharides and alcohols (34.15%), steroids (16.67%), alkaloids (12.24%), flavonoids (9.28%), and glycerophospholipids (7.41%). Conversely, nucleotides and derivatives experienced the greatest up-regulation in the waterlogged soil, accounting for 50.00% of the total metabolites. In conclusion, waterlogging negatively impacted the growth of G. sinensis seedlings and inhibited the accumulation of metabolites. Hence, when considering the accumulation of secondary metabolites such as lignans and phenolic acids, appropriate management of soil moisture levels should be taken into account.


Sujet(s)
Gleditsia , Lignanes , Plant , Lignanes/métabolisme , Gleditsia/composition chimique , Extraits de plantes/métabolisme , Racines de plante
2.
Proc Natl Acad Sci U S A ; 119(25): e2123265119, 2022 06 21.
Article de Anglais | MEDLINE | ID: mdl-35700359

RÉSUMÉ

Metabolic aberrations impact the pathogenesis of multiple sclerosis (MS) and possibly can provide clues for new treatment strategies. Using untargeted metabolomics, we measured serum metabolites from 35 patients with relapsing-remitting multiple sclerosis (RRMS) and 14 healthy age-matched controls. Of 632 known metabolites detected, 60 were significantly altered in RRMS. Bioinformatics analysis identified an altered metabotype in patients with RRMS, represented by four changed metabolic pathways of glycerophospholipid, citrate cycle, sphingolipid, and pyruvate metabolism. Interestingly, the common upstream metabolic pathway feeding these four pathways is the glycolysis pathway. Real-time bioenergetic analysis of the patient-derived peripheral blood mononuclear cells showed enhanced glycolysis, supporting the altered metabolic state of immune cells. Experimental autoimmune encephalomyelitis mice treated with the glycolytic inhibitor 2-deoxy-D-glucose ameliorated the disease progression and inhibited the disease pathology significantly by promoting the antiinflammatory phenotype of monocytes/macrophage in the central nervous system. Our study provided a proof of principle for how a blood-based metabolomic approach using patient samples could lead to the identification of a therapeutic target for developing potential therapy.


Sujet(s)
Développement de médicament , Glycolyse , Métabolomique , Sclérose en plaques récurrente-rémittente , Animaux , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/usage thérapeutique , Antimétabolites/pharmacologie , Antimétabolites/usage thérapeutique , Désoxyglucose/pharmacologie , Désoxyglucose/usage thérapeutique , Développement de médicament/méthodes , Encéphalomyélite auto-immune expérimentale/traitement médicamenteux , Encéphalomyélite auto-immune expérimentale/métabolisme , Glycolyse/effets des médicaments et des substances chimiques , Humains , Agranulocytes/métabolisme , Souris , Sclérose en plaques récurrente-rémittente/sang , Sclérose en plaques récurrente-rémittente/traitement médicamenteux , Sclérose en plaques récurrente-rémittente/métabolisme
4.
Sci Rep ; 9(1): 16762, 2019 11 14.
Article de Anglais | MEDLINE | ID: mdl-31728043

RÉSUMÉ

The 2008 Wenchuan earthquake caused significant economic losses and degradation of regional ecosystems, including the terrestrial vegetation. Since the vegetation root system can enhance the soil's anti-erosion capacity and therefore mitigate the occurrence of slope instabilities, it is beneficial to study the spatial and temporal evolution of vegetation for a long-term assessment of co-seismic secondary disasters. The Mianyuan River Basin, an uninhabited area passing through an active fault located in the earthquake-affected region, was selected as the study area. The Normal Difference Vegetation Index (NDVI) was calculated using remote sensing images from 1994 to 2017 to analyze the process of vegetation growth, loss, fluctuation and recovery. Statistical results suggest that the area in the middle and lower reaches, near the river network, and with a slope of 30 to 40 degrees were variable regions, showing more significant vegetation destruction during the earthquake and faster repair after the seismic event. Besides, vegetation near the fault was damaged more severely after the earthquake, but the active fault did not play an essential role in the vegetation recovery period. In the Mianyuan River Basin, vegetation experienced a volatility period (5 plus or minus one year) before entering the recovery period. In 8 to 9 years after the earthquake, the surficial vegetation could recover to the state before the earthquake.

5.
Atherosclerosis ; 290: 125-135, 2019 11.
Article de Anglais | MEDLINE | ID: mdl-31614249

RÉSUMÉ

BACKGROUND AND AIMS: Hyperlipidemia-induced atherosclerosis is the major cause of heart attack and stroke in humans. However, pathological details and molecular mechanisms underlying early atherogenesis remain incompletely characterized. This study explored the early events of atherogenesis in a hypercholesterolemic zebrafish model in vivo. METHODS: We used transparent transgenic zebrafish larvae Tg(lysc:EGFP), Tg(mpx:EGFP), Tg(mpeg1:EGFP), Tg(flk1:EGFP) or Tg(lysc:EGFP/flk1:mCherry), together with fluorescently labeled control and high cholesterol diets (HCD), to dynamically investigate the early development of atherosclerosis with confocal in vivo. Endothelial cells with green fluorescence were sorted by fluorescence-activated cell sorting (FACS) to detect gene expression. Moreover, we treated hypercholesterolemic zebrafish model in vivo or human umbilical vein endothelial cells (HUVEC) in vitro with rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ (PPARγ). RESULTS: We found that HCD-induced endothelial inflammation was an earlier pathological alteration than myeloid cells/neutrophils accumulation and lipid deposition in zebrafish vascular vessels of HCD-fed zebrafish. Endothelial inflammation was characterized by down-regulation of anti-inflammatory PPARγ and upregulation of pro-inflammatory tumor necrosis factor α (TNF-α) and interleukin-1ß (IL-1ß). Pharmacological treatment with rosiglitazone reversed the decrease in the expression of PPARγ and decreased expression of TNF-α and IL-1ß in HCD-fed zebrafish. Moreover, rosiglitazone ameliorated myeloid cells accumulation and lipid deposition in HCD-fed zebrafish in vivo. CONCLUSIONS: Hyperlipidemia-induced endothelial inflammation happens earlier than myeloid cell neutrophils accumulation in vascular vessels, and neutrophils accumulation is prior to lipid deposition during the initial stage of atherosclerosis. Early alleviation of inflammation induced by HCD would have a prophylactic effect for the initial development of atherosclerosis.


Sujet(s)
Athérosclérose/métabolisme , Cholestérol alimentaire , Cellules endothéliales/métabolisme , Hypercholestérolémie/métabolisme , Inflammation/métabolisme , Métabolisme lipidique , Microscopie confocale , Infiltration par les neutrophiles , Animaux , Animal génétiquement modifié , Anti-inflammatoires/pharmacologie , Athérosclérose/génétique , Athérosclérose/anatomopathologie , Athérosclérose/prévention et contrôle , Modèles animaux de maladie humaine , Cellules endothéliales/effets des médicaments et des substances chimiques , Cellules endothéliales/anatomopathologie , Cellules endothéliales de la veine ombilicale humaine/métabolisme , Humains , Hypercholestérolémie/traitement médicamenteux , Hypercholestérolémie/génétique , Hypercholestérolémie/anatomopathologie , Inflammation/génétique , Inflammation/anatomopathologie , Inflammation/prévention et contrôle , Interleukine-1 bêta/métabolisme , Récepteur PPAR gamma/agonistes , Récepteur PPAR gamma/métabolisme , Plaque d'athérosclérose , Rosiglitazone/pharmacologie , Facteurs temps , Facteur de nécrose tumorale alpha/métabolisme , Danio zébré , Protéines de poisson-zèbre/métabolisme
6.
Pharmacol Res ; 134: 1-15, 2018 08.
Article de Anglais | MEDLINE | ID: mdl-29772270

RÉSUMÉ

Panax notoginseng (Burkill) F. H. Chen ex C. H. Chow (P. notoginseng) is a highly valued Chinese materia medica having a hemostatic effect and mainly used for the treatment of trauma and ischemic cardiovascular diseases. Stringent growth requirements, weak resistance to insect pests and plant diseases, arsenic contamination and continuous cropping constitute hurdles to further increases in the agricultural production of P. notoginseng. This review focuses on the traditional uses (based on traditional Chinese medicine theory), major chemical components, biological activities, pharmacological properties, geographical distributions and historical development of taxonomy of P. notoginseng and its related species in Panax genus, including Panax japonicus C. A. Meyer (P. japonicus), Panax japonicus C. A. Meyer var. major (Burkill) C. Y. Wu et K. M. Feng (P. japonicus var. major) and Panax japonicus C. A. Meyer var. bipinnatifidus (Seem.) C. Y. Wu et K. M. Feng (P. japonicus var. bipinnatifidus) are reviewed. This review sheds light on the origin herbs of Zhujieshen (ZJS) and Zhuzishen (ZZS), e.g., P. japonicas var japonicas, P. japonicus var. major and P. japonicus var. bipinnatifidus could be used as a substitute for P. notoginseng as hemostatic herbs.


Sujet(s)
Médicaments issus de plantes chinoises/usage thérapeutique , Hémostatiques/usage thérapeutique , Panax notoginseng/classification , Panax/classification , Animaux , Médicaments issus de plantes chinoises/effets indésirables , Médicaments issus de plantes chinoises/isolement et purification , Médicaments issus de plantes chinoises/ressources et distribution , Hémostatiques/effets indésirables , Hémostatiques/isolement et purification , Hémostatiques/ressources et distribution , Humains , Panax/croissance et développement , Panax notoginseng/croissance et développement
7.
Article de Anglais | WPRIM (Pacifique Occidental) | ID: wpr-691393

RÉSUMÉ

<p><b>OBJECTIVE</b>To investigate the pro-angiogenic effects of paeoniflorin (PF) in a vascular insufficiency model of zebrafish and in human umbilical vein endothelial cells (HUVECs).</p><p><b>METHODS</b>In vivo, the pro-angiogenic effects of PF were tested in a vascular insufficiency model in the Tg(fli-1:EGFP)y1 transgenic zebrafish. The 24 h post fertilization (hpf) embryos were pretreated with vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor II (VRI) for 3 h to establish the vascular insufficiency model and then post-treated with PF for 24 h. The formation of intersegmental vessels (ISVs) was observed with a fluorescence microscope. The mRNA expression of fms-like tyrosine kinase-1 (flt-1), kinase insert domain receptor (kdr), kinase insert domain receptor like (kdrl) and von Willebrand factor (vWF) were analyzed by real-time polymerase chain reaction (PCR). In vitro, the pro-angiogenic effects of PF were observed in HUVECs in which cell proliferation, migration and tube formation were assessed.</p><p><b>RESULTS</b>PF (6.25-100 μmol/L) could rescue VRI-induced blood vessel loss in zebrafish and PF (25-100 μmol/L), thereby restoring the mRNA expressions of flt-1, kdr, kdrl and vWF, which were down-regulated by VRI treatment. In addition, PF (0.001-0.03 μmol/L) could promote the proliferation of HUVECs while PF stimulated HUVECs migration at 1.0-10 μmol/L and tube formation at 0.3 μmol/L.</p><p><b>CONCLUSION</b>PF could promote angiogenesis in a vascular insufficiency model of zebrafish in vivo and in HUVECs in vitro.</p>


Sujet(s)
Animaux , Humains , Agents angiogéniques , Pharmacologie , Utilisations thérapeutiques , Animal génétiquement modifié , Cellules cultivées , Modèles animaux de maladie humaine , Médicaments issus de plantes chinoises , Pharmacologie , Utilisations thérapeutiques , Embryon non mammalien , Glucosides , Pharmacologie , Utilisations thérapeutiques , Cellules endothéliales de la veine ombilicale humaine , Physiologie , Monoterpènes , Pharmacologie , Utilisations thérapeutiques , Néovascularisation physiologique , Phytothérapie , Maladies vasculaires , Traitement médicamenteux , Anatomopathologie , Danio zébré
8.
Chin J Integr Med ; 24(7): 494-501, 2018 Jul.
Article de Anglais | MEDLINE | ID: mdl-27286711

RÉSUMÉ

OBJECTIVE: To investigate the pro-angiogenic effects of paeoniflorin (PF) in a vascular insufficiency model of zebrafish and in human umbilical vein endothelial cells (HUVECs). METHODS: In vivo, the pro-angiogenic effects of PF were tested in a vascular insufficiency model in the Tg(fli-1:EGFP)y1 transgenic zebrafish. The 24 h post fertilization (hpf) embryos were pretreated with vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor II (VRI) for 3 h to establish the vascular insufficiency model and then post-treated with PF for 24 h. The formation of intersegmental vessels (ISVs) was observed with a fluorescence microscope. The mRNA expression of fms-like tyrosine kinase-1 (flt-1), kinase insert domain receptor (kdr), kinase insert domain receptor like (kdrl) and von Willebrand factor (vWF) were analyzed by real-time polymerase chain reaction (PCR). In vitro, the pro-angiogenic effects of PF were observed in HUVECs in which cell proliferation, migration and tube formation were assessed. RESULTS: PF (6.25-100 µmol/L) could rescue VRI-induced blood vessel loss in zebrafish and PF (25-100 µmol/L), thereby restoring the mRNA expressions of flt-1, kdr, kdrl and vWF, which were down-regulated by VRI treatment. In addition, PF (0.001-0.03 µmol/L) could promote the proliferation of HUVECs while PF stimulated HUVECs migration at 1.0-10 µmol/L and tube formation at 0.3 µmol/L. CONCLUSION: PF could promote angiogenesis in a vascular insufficiency model of zebrafish in vivo and in HUVECs in vitro.


Sujet(s)
Agents angiogéniques/usage thérapeutique , Glucosides/usage thérapeutique , Cellules endothéliales de la veine ombilicale humaine/effets des médicaments et des substances chimiques , Monoterpènes/usage thérapeutique , Néovascularisation physiologique/effets des médicaments et des substances chimiques , Maladies vasculaires/traitement médicamenteux , Maladies vasculaires/anatomopathologie , Agents angiogéniques/pharmacologie , Animaux , Animal génétiquement modifié , Cellules cultivées , Modèles animaux de maladie humaine , Médicaments issus de plantes chinoises/pharmacologie , Médicaments issus de plantes chinoises/usage thérapeutique , Embryon non mammalien , Glucosides/pharmacologie , Cellules endothéliales de la veine ombilicale humaine/physiologie , Humains , Monoterpènes/pharmacologie , Phytothérapie , Danio zébré
9.
Chin J Integr Med ; 23(9): 654-662, 2017 Sep.
Article de Anglais | MEDLINE | ID: mdl-28551771

RÉSUMÉ

OBJECTIVE: To investigate the synergistic effects of Chuanxiong-Chishao herb-pair (CCHP) on promoting angiogenesis in silico and in vivo. METHODS: The mechanisms of action of an herb-pair, Chuanxiong-Chishao, were investigated using the network pharmacological and pharmacodynamic strategies involving computational drug target prediction and network analysis, and experimental validation. A set of network pharmacology methods were created to study the herbs in the context of targets and diseases networks, including prediction of target profiles and pharmacological actions of main active compounds in Chuanxiong and Chishao. Furthermore, the therapeutic effects and putative molecular mechanisms of Chuanxiong-Chishao actions were experimentally validated in a chemical-induced vascular insuffificiency model of transgenic zebrafifish in vivo. The mRNA expression of the predicted targets were further analyzed by real-time polymerase chain reaction (RT-PCR). RESULTS: The computational prediction results found that the compounds in Chuanxiong have antithrombotic, antihypertensive, antiarrhythmic, and antiatherosclerotic activities, which were closely related to protecting against hypoxic-ischemic encephalopathy, ischemic stroke, myocardial infarction and heart failure. In addition, compounds in Chishao were found to participate in anti-inflflammatory effect and analgesics. Particularly, estrogen receptor α (ESRα) and hypoxia-inducible factor 1-α (HIF-1α) were the most important potential protein targets in the predicted results. In vivo experimental validation showed that post-treatment of tetramethylpyrazine hydrochloride (TMP•HCl) and paeoniflorin (PF) promoted the regeneration of new blood vessels in zebrafifish involving up-regulating ESRα mRNA expression. Co-treatment of TMP•HCl and PF could enhance the vessel sprouting in chemical-induced vascular insuffificiency zebrafifish at the optimal compatibility proportion of PF 10 µmol/L with TMP•HCl 1 µmol/L. CONCLUSIONS: The network pharmacological strategies combining drug target prediction and network analysis identified some putative targets of CCHP. Moreover, the transgenic zebrafifish experiments demonstrated that the Chuanxiong-Chishao combination synergistically promoted angiogenic activity, probably involving ESRα signaling pathway.


Sujet(s)
Médicaments issus de plantes chinoises/pharmacologie , Néovascularisation physiologique/effets des médicaments et des substances chimiques , Animaux , Maladies cardiovasculaires/traitement médicamenteux , Maladies cardiovasculaires/physiopathologie , Synergie des médicaments , Médicaments issus de plantes chinoises/usage thérapeutique , Embryon non mammalien/effets des médicaments et des substances chimiques , Récepteur alpha des oestrogènes/génétique , Récepteur alpha des oestrogènes/métabolisme , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Glucosides/composition chimique , Ligands , Monoterpènes/composition chimique , Néovascularisation physiologique/génétique , Pyrazines/composition chimique , Reproductibilité des résultats , Danio zébré/embryologie
10.
Article de Anglais | WPRIM (Pacifique Occidental) | ID: wpr-327188

RÉSUMÉ

<p><b>OBJECTIVE</b>To investigate the synergistic effects of Chuanxiong-Chishao herb-pair (CCHP) on promoting angiogenesis in silico and in vivo.</p><p><b>METHODS</b>The mechanisms of action of an herb-pair, Chuanxiong-Chishao, were investigated using the network pharmacological and pharmacodynamic strategies involving computational drug target prediction and network analysis, and experimental validation. A set of network pharmacology methods were created to study the herbs in the context of targets and diseases networks, including prediction of target profiles and pharmacological actions of main active compounds in Chuanxiong and Chishao. Furthermore, the therapeutic effects and putative molecular mechanisms of Chuanxiong-Chishao actions were experimentally validated in a chemical-induced vascular insuffificiency model of transgenic zebrafifish in vivo. The mRNA expression of the predicted targets were further analyzed by real-time polymerase chain reaction (RT-PCR).</p><p><b>RESULTS</b>The computational prediction results found that the compounds in Chuanxiong have antithrombotic, antihypertensive, antiarrhythmic, and antiatherosclerotic activities, which were closely related to protecting against hypoxic-ischemic encephalopathy, ischemic stroke, myocardial infarction and heart failure. In addition, compounds in Chishao were found to participate in anti-inflflammatory effect and analgesics. Particularly, estrogen receptor α (ESRα) and hypoxia-inducible factor 1-α (HIF-1α) were the most important potential protein targets in the predicted results. In vivo experimental validation showed that post-treatment of tetramethylpyrazine hydrochloride (TMP•HCl) and paeoniflorin (PF) promoted the regeneration of new blood vessels in zebrafifish involving up-regulating ESRα mRNA expression. Co-treatment of TMP•HCl and PF could enhance the vessel sprouting in chemical-induced vascular insuffificiency zebrafifish at the optimal compatibility proportion of PF 10 μmol/L with TMP•HCl 1 μmol/L.</p><p><b>CONCLUSIONS</b>The network pharmacological strategies combining drug target prediction and network analysis identified some putative targets of CCHP. Moreover, the transgenic zebrafifish experiments demonstrated that the Chuanxiong-Chishao combination synergistically promoted angiogenic activity, probably involving ESRα signaling pathway.</p>

11.
Drug Evaluation Research ; (6): 1631-1634, 2017.
Article de Chinois | WPRIM (Pacifique Occidental) | ID: wpr-664611

RÉSUMÉ

Objective To investigate the effect of citalopram hydrobromide tablets on cognitive function and inflammatory factors in patients with recurrent bipolar disorder (BPD),and to analyze its possible mechanism of action.Methods 104 patients with recurrent BPD in our hospital from July 2014 to December 2015 were selected,and they were divided into observation group and control group by random number table,52 cases in each group.Control group was given sodium valproate,while observation group was given citalopram hydrobromide tablets and sodium valproate.After 8-week treatment,the emotional state,cognitive function,inflammatory factors were compared between the two groups.Results Before treatment,HAMD score,BPMS score of two groups were not statistically significant.After 8 weeks of treatment,HAMD score and BPMS score of two groups were significantly lower than those in the same group before treatment (P < 0.01);and the observation group HAMD score and BPMS score were significantly lower than the control group (P < 0.01).Before treatment,TMT-A,TMT-B time of two groups were not statistically significant.After 8 weeks of treatment,TMT-A and TMT-B time of two groups were significantly shorter than the same group before treatment (P < 0.05).TMT-A TMT-B in the observation group were significantly shorter than the control group (P < 0.05).The content of serum MIF,IL-1 beta and IL-6 in two groups before treatment were not statistically significant.After 8 weeks of treatment,the contents ofMIF,IL-1 beta,IL-6 in two groups were significantly lower than the same group before treatment (P < 0.05).And the levels of serum MIF,IL-1 beta,IL-6 in observation group were significantly lower than the control group (P < 0.05).Conclusion Citalopram hydrobromide tablets can relieve clinical symptoms,improve cognitive function,and it possibly has relations with inhibiting the expression of inflammatory factors.

12.
World J Gastroenterol ; 23(47): 8321-8333, 2017 Dec 21.
Article de Anglais | MEDLINE | ID: mdl-29307992

RÉSUMÉ

AIM: To determine whether fructo-oligosaccharide (FOS) affects visceral sensitivity, inflammation, and production of intestinal short-chain fatty acids (SCFA) in an irritable bowel syndrome (IBS) mouse model. METHODS: Mice were randomly assigned to daily oral gavage of saline solution with or without FOS (8 g/kg body weight) for 14 d. Mice were further assigned to receive either daily one-hour water avoidance stress (WAS) or sham-WAS for the first 10 d. After 2 wk, visceral sensitivity was measured by abdominal withdrawal reflex in response to colorectal distension and mucosal inflammation was evaluated. Gas chromatography, real-time reverse transcription PCR, and immunohistochemistry assays were used to quantify cecal concentrations of SCFA, intestinal cytokine expression, and number of intestinal mast cells per high-power field (HPF), respectively. RESULTS: Mice subjected to WAS exhibited visceral hypersensitivity and low-grade inflammation. Among mice subjected to WAS, FOS increased visceral hypersensitivity and led to higher cecal concentrations of acetic acid (2.49 ± 0.63 mmol/L vs 1.49 ± 0.72 mmol/L, P < 0.05), propionic acid (0.48 ± 0.09 mmol/L vs 0.36 ± 0.05 mmol/L, P < 0.01), butyric acid (0.28 ± 0.09 mmol/L vs 0.19 ± 0.003 mmol/L, P < 0.05), as well as total SCFA (3.62 ± 0.87 mmol/L vs 2.27 ± 0.75 mmol/L, P < 0.01) compared to saline administration. FOS also increased ileal interleukin (IL)-23 mRNA (4.71 ± 4.16 vs 1.00 ± 0.99, P < 0.05) and colonic IL-1ß mRNA (2.15 ± 1.68 vs 0.88 ± 0.53, P < 0.05) expressions as well as increased mean mast cell counts in the ileum (12.3 ± 2.6 per HPF vs 8.3 ± 3.6 per HPF, P < 0.05) and colon (6.3 ± 3.2 per HPF vs 3.4 ± 1.2 per HPF, P < 0.05) compared to saline administration in mice subjected to WAS. No difference in visceral sensitivity, intestinal inflammation, or cecal SCFA levels was detected with or without FOS administration in mice subjected to sham-WAS. CONCLUSION: FOS administration intensifies visceral hypersensitivity and gut inflammation in stress-induced IBS mice, but not in the control mice, and is also associated with increased intestinal SCFA production.


Sujet(s)
Hypersensibilité alimentaire/immunologie , Muqueuse intestinale/immunologie , Intestins/immunologie , Syndrome du côlon irritable/immunologie , Oligosaccharides/immunologie , Animaux , Cytokines/métabolisme , Modèles animaux de maladie humaine , Acides gras volatils/métabolisme , Femelle , Humains , Muqueuse intestinale/anatomopathologie , Intestins/cytologie , Intestins/anatomopathologie , Syndrome du côlon irritable/anatomopathologie , Mastocytes/immunologie , Souris , Souris de lignée C57BL , Seuils sensoriels , Stress psychologique/complications
13.
World J Gastroenterol ; 22(12): 3486-95, 2016 Mar 28.
Article de Anglais | MEDLINE | ID: mdl-27022230

RÉSUMÉ

AIM: To evaluate whether Helicobacter pylori (H. pylori) eradication therapy benefits patients with functional dyspepsia (FD). METHODS: Randomized controlled trials (RCTs) investigating the efficacy and safety of H. pylori eradication therapy for patients with functional dyspepsia published in English (up to May 2015) were identified by searching PubMed, EMBASE, and The Cochrane Library. Pooled estimates were measured using the fixed or random effect model. Overall effect was expressed as a pooled risk ratio (RR) or a standard mean difference (SMD). All data were analyzed with Review Manager 5.3 and Stata 12.0. RESULTS: This systematic review included 25 RCTs with a total of 5555 patients with FD. Twenty-three of these studies were used to evaluate the benefits of H. pylori eradication therapy for symptom improvement; the pooled RR was 1.23 (95%CI: 1.12-1.36, P < 0.0001). H. pylori eradication therapy demonstrated symptom improvement during long-term follow-up at ≥ 1 year (RR = 1.24; 95%CI: 1.12-1.37, P < 0.0001) but not during short-term follow-up at < 1 year (RR = 1.26; 95%CI: 0.83-1.92, P = 0.27). Seven studies showed no benefit of H. pylori eradication therapy on quality of life with an SMD of -0.01 (95%CI: -0.11 to 0.08, P = 0.80). Six studies demonstrated that H. pylori eradication therapy reduced the development of peptic ulcer disease compared to no eradication therapy (RR = 0.35; 95%CI: 0.18-0.68, P = 0.002). Eight studies showed that H. pylori eradication therapy increased the likelihood of treatment-related side effects compared to no eradication therapy (RR = 2.02; 95%CI: 1.12-3.65, P = 0.02). Ten studies demonstrated that patients who received H. pylori eradication therapy were more likely to obtain histologic resolution of chronic gastritis compared to those who did not receive eradication therapy (RR = 7.13; 95%CI: 3.68-13.81, P < 0.00001). CONCLUSION: The decision to eradicate H. pylori in patients with functional dyspepsia requires individual assessment.


Sujet(s)
Antibactériens/usage thérapeutique , Dyspepsie/traitement médicamenteux , Infections à Helicobacter/traitement médicamenteux , Helicobacter pylori/effets des médicaments et des substances chimiques , Inhibiteurs de la pompe à protons/usage thérapeutique , Adulte , Loi du khi-deux , Association de médicaments , Dyspepsie/diagnostic , Dyspepsie/microbiologie , Femelle , Infections à Helicobacter/diagnostic , Infections à Helicobacter/microbiologie , Helicobacter pylori/pathogénicité , Humains , Mâle , Adulte d'âge moyen , Odds ratio , Induction de rémission , Facteurs de risque , Résultat thérapeutique
14.
J Ethnopharmacol ; 181: 50-8, 2016 Apr 02.
Article de Anglais | MEDLINE | ID: mdl-26806572

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: The root of Panax notoginseng is traditionally used as an anti-hemorrhagic agent to promote blood circulation without causing "congealed" blood. Furthermore, the flower of P. notoginseng is a popular, traditional medicine taken daily for the preventing of hypertension and for reducing blood cholesterol profiles. Besides, the flower of P. notoginseng contains a higher level of saponins, particularly protopanaxadiol-type ginsenosides, as compared to the root. However, detailed pharmacological studies on this flower have rarely been conducted. MATERIAL AND METHODS: In this study, the saponins extracted from the flower of P. notoginseng (FS) were examined on the endothelial cell migration assay, chemically induced vascular insufficiency model in zebrafish larvae and myocardial infraction (MI) model in rats, for determination of their pro-angiogenic and therapeutic effects on MI treatment. RESULTS: Our results demonstrate that FS significantly promoted VEGF-induced migration of human umbilical vein endothelial cells (HUVECs) and partially restored defective intersegmental vessels (ISV) in a chemically induced vascular insufficiency model of zebrafish larvae. When compared to MI group, two weeks post-treatment of FS (25-50mg/kg/day) induced approximately 3-fold upregulation of VEGF mRNA expression and a concomitant increase in blood vessel density in the peri-infarct area of the heart. Moreover, TUNEL analysis indicates a reduction in the mean apoptotic nuclei per field in peri-infarct myocardium upon FS treatment. CONCLUSIONS: The pro-angiogenic effects of FS demonstrated in in vitro and in vivo experimental models suggest that the purified saponin preparation from flowers of P. notoginseng may potentially provide preventive and therapeutic agent for cardiovascular diseases.


Sujet(s)
Inhibiteurs de l'angiogenèse/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Fleurs/composition chimique , Infarctus du myocarde/traitement médicamenteux , Néovascularisation pathologique/traitement médicamenteux , Panax notoginseng/composition chimique , Saponines/pharmacologie , Animaux , Mouvement cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Ginsénosides/pharmacologie , Coeur/effets des médicaments et des substances chimiques , Cellules endothéliales de la veine ombilicale humaine/effets des médicaments et des substances chimiques , Cellules endothéliales de la veine ombilicale humaine/métabolisme , Humains , Méthode TUNEL/méthodes , Larve/effets des médicaments et des substances chimiques , Larve/métabolisme , Mâle , Infarctus du myocarde/métabolisme , Néovascularisation pathologique/métabolisme , ARN messager/métabolisme , Rats , Rat Sprague-Dawley , Facteur de croissance endothéliale vasculaire de type A/métabolisme , Danio zébré
15.
Guang Pu Xue Yu Guang Pu Fen Xi ; 36(5): 1445-50, 2016 May.
Article de Chinois | MEDLINE | ID: mdl-30001028

RÉSUMÉ

Facial paralysis which is mainly caused by facial nerve dysfunction is a common clinical entity. It seriously devastates a patient's daily life and interpersonal relationships. A method of automatic assessment of facial nerve function is of critical importance for the diagnosis and treatment of facial paralysis. The contralateral asymmetry of facial temperature distribution is one of the newly symptoms of facial paralysis patients which can be captured by infrared thermography. This paper presents a novel framework for objective measurement of facial paralysis based on the automatic analysis of infrared thermal image. Facial infrared thermal image is automatically divided into eight regional areas based on facial temperature distribution specificity and edge detection, the facial temperature distribution features are extracted automatically, including the asymmetry degree of facial temperature distribution, effective thermal area ratio and temperature difference. The automatic classifier is used to assess facial nerve function based on radial basis function neural network (RBFNN). This method comprehensively utilizes the correlation and specificity of the facial temperature distribution,extracts efficiently the facial temperature contralateral asymmetry of facial paralysis in the infrared thermal imaging. In our experiments, 390 infrared thermal images were collected from subjects with unilateral facial paralysis. The results show: the average classification accuracy rate of our proposed method was 94.10%. It has achieved a better classification rate which is above 9.31% than K nearest neighbor (kNN) classifier and 4.87% above Support vector machine (SVM). This experiment results is superior to traditional House-Brackmann facial neural function assessment method. The classification accuracy of facial nerve function with the method is full compliance with the clinical application standard. A complete set of automated techniques for the computerized assessment of thermal images has been developed to assess thermal dysfunction caused by facial paralysis, and the clinical diagnosis and treatment of facial paralysis also will benefit by this method.


Sujet(s)
Nerf facial , Paralysie faciale , Température du corps , Humains , , Machine à vecteur de support
16.
Chin J Integr Med ; 22(6): 420-9, 2016 Jun.
Article de Anglais | MEDLINE | ID: mdl-25533511

RÉSUMÉ

OBJECTIVE: This study aimed at investigating whether notoginsenoside R1 (R1), a unique saponin found in Panax notoginseng could promote angiogenic activity on human umbilical vein endothelial cells (HUVECs) and elucidate their potential molecular mechanisms. In addition, vascular restorative activities of R1 was assessed in a chemically-induced blood vessel loss model in zebrafish. METHODS: The in vitro angiogenic effect of R1 was compared with other previously reported angiogenic saponins Rg1 and Re. The HUVECs proliferation in the presence of R1 was determined by cell proliferation kit II (XTT) assay. R1, Rg1 and Re-induced HUVECs invasion across polycarbonate membrane was stained with Hoechst-33342 and quantified microscopically. Tube formation assay using matrigelcoated wells was performed to evaluate the pro-angiogenic actions of R1. In order to understand the mechanism underlying the pro-angiogenic effect, various pathway inhibitors such as SU5416, wortmannin (wort) or L-Nω-nitro- L-arginine methyl ester hydrochloride (L-NAME), SH-6 were used to probe the possible involvement of signaling pathway in the R1 mediated HUVECs proliferation. In in vivo assays, zebrafish embryos at 21 hpf were pre-treated with vascular endothelial growth factor (VEGF) receptor kinase inhibitor II (VRI) for 3 h only and subsequently post-treated with R1 for 48 h, respectively. The intersegmental vessels (ISVs) in zebrafish were assessed for the restorative effect of R1 on defective blood vessels. RESULTS: R1 could stimulate the proliferation of HUVECs. In the chemoinvasion assay, R1 significantly increased the number of cross-membrane HUVECs. In addition, R1 markedly enhanced the tube formation ability of HUVECs. The proliferative effects of these saponins on HUVECs were effectively blocked by the addition of SU5416 (a VEGF-KDR/Flk-1 inhibitor). Similarly, pre-treatment with wort [a phosphatidylinositol 3-kinase (PI3K)-kinase inhibitor], L-NAME [an endothelial nitric oxide synthase (eNOS) inhibitor] or SH-6 (an Akt pathway inhibitor) significantly abrogated the R1 induced proliferation of HUVECs. In chemicallyinduced blood vessel loss model in zebrafish, R1 significantly rescue the damaged ISVs. CONCLUSION: R1, similar to Rg1 and Re, had been showed pro-angiogenic action, possibly via the activation of the VEGF-KDR/Flk-1 and PI3K-Akt-eNOS signaling pathways. Our findings also shed light on intriguing pro-angiogenic effect of R1 under deficient angiogenesis condition in a pharmacologic-induced blood vessels loss model in zebrafish. The present study in vivo and in vitro provided scientific evidence to explain the ethnomedical use of Panax notoginseng in the treatment of cardiovascular diseases, traumatic injuries and wound healing.


Sujet(s)
Vaisseaux sanguins/anatomopathologie , Ginsénosides/pharmacologie , Cellules endothéliales de la veine ombilicale humaine/physiologie , Néovascularisation physiologique/effets des médicaments et des substances chimiques , Animaux , Mouvement cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Collagène/pharmacologie , Modèles animaux de maladie humaine , Association médicamenteuse , Ginsénosides/composition chimique , Cellules endothéliales de la veine ombilicale humaine/cytologie , Cellules endothéliales de la veine ombilicale humaine/effets des médicaments et des substances chimiques , Cellules endothéliales de la veine ombilicale humaine/enzymologie , Humains , Laminine/pharmacologie , Phosphatidylinositol 3-kinases/métabolisme , Inhibiteurs de protéines kinases/pharmacologie , Protéoglycanes/pharmacologie , Protéines proto-oncogènes c-akt/métabolisme , Récepteur-2 au facteur croissance endothéliale vasculaire/métabolisme , Danio zébré
17.
Article de Anglais | WPRIM (Pacifique Occidental) | ID: wpr-310860

RÉSUMÉ

<p><b>OBJECTIVE</b>This study aimed at investigating whether notoginsenoside R1 (R1), a unique saponin found in Panax notoginseng could promote angiogenic activity on human umbilical vein endothelial cells (HUVECs) and elucidate their potential molecular mechanisms. In addition, vascular restorative activities of R1 was assessed in a chemically-induced blood vessel loss model in zebrafish.</p><p><b>METHODS</b>The in vitro angiogenic effect of R1 was compared with other previously reported angiogenic saponins Rg1 and Re. The HUVECs proliferation in the presence of R1 was determined by cell proliferation kit II (XTT) assay. R1, Rg1 and Re-induced HUVECs invasion across polycarbonate membrane was stained with Hoechst-33342 and quantified microscopically. Tube formation assay using matrigelcoated wells was performed to evaluate the pro-angiogenic actions of R1. In order to understand the mechanism underlying the pro-angiogenic effect, various pathway inhibitors such as SU5416, wortmannin (wort) or L-Nω-nitro- L-arginine methyl ester hydrochloride (L-NAME), SH-6 were used to probe the possible involvement of signaling pathway in the R1 mediated HUVECs proliferation. In in vivo assays, zebrafish embryos at 21 hpf were pre-treated with vascular endothelial growth factor (VEGF) receptor kinase inhibitor II (VRI) for 3 h only and subsequently post-treated with R1 for 48 h, respectively. The intersegmental vessels (ISVs) in zebrafish were assessed for the restorative effect of R1 on defective blood vessels.</p><p><b>RESULTS</b>R1 could stimulate the proliferation of HUVECs. In the chemoinvasion assay, R1 significantly increased the number of cross-membrane HUVECs. In addition, R1 markedly enhanced the tube formation ability of HUVECs. The proliferative effects of these saponins on HUVECs were effectively blocked by the addition of SU5416 (a VEGF-KDR/Flk-1 inhibitor). Similarly, pre-treatment with wort [a phosphatidylinositol 3-kinase (PI3K)-kinase inhibitor], L-NAME [an endothelial nitric oxide synthase (eNOS) inhibitor] or SH-6 (an Akt pathway inhibitor) significantly abrogated the R1 induced proliferation of HUVECs. In chemicallyinduced blood vessel loss model in zebrafish, R1 significantly rescue the damaged ISVs.</p><p><b>CONCLUSION</b>R1, similar to Rg1 and Re, had been showed pro-angiogenic action, possibly via the activation of the VEGF-KDR/Flk-1 and PI3K-Akt-eNOS signaling pathways. Our findings also shed light on intriguing pro-angiogenic effect of R1 under deficient angiogenesis condition in a pharmacologic-induced blood vessels loss model in zebrafish. The present study in vivo and in vitro provided scientific evidence to explain the ethnomedical use of Panax notoginseng in the treatment of cardiovascular diseases, traumatic injuries and wound healing.</p>


Sujet(s)
Animaux , Humains , Vaisseaux sanguins , Anatomopathologie , Mouvement cellulaire , Prolifération cellulaire , Collagène , Pharmacologie , Modèles animaux de maladie humaine , Association médicamenteuse , Ginsénosides , Chimie , Pharmacologie , Cellules endothéliales de la veine ombilicale humaine , Biologie cellulaire , Physiologie , Laminine , Pharmacologie , Néovascularisation physiologique , Phosphatidylinositol 3-kinases , Métabolisme , Inhibiteurs de protéines kinases , Pharmacologie , Protéoglycanes , Pharmacologie , Protéines proto-oncogènes c-akt , Métabolisme , Récepteur-2 au facteur croissance endothéliale vasculaire , Métabolisme , Danio zébré
18.
BMC Genomics ; 16: 265, 2015 Apr 03.
Article de Anglais | MEDLINE | ID: mdl-25886736

RÉSUMÉ

BACKGROUND: Panax notoginseng (Burk.) F.H. Chen is one of the most highly valued medicinal plants in the world. The major bioactive molecules are triterpene saponins, which are also known as ginsenosides. However, its large genome size has hindered the assembly of a draft genome by whole genome sequencing. Hence, genomic and transcriptomic details about P. notoginseng, especially its biosynthetic pathways and gene expression in different parts of the plant, have remained largely unknown until now. RESULTS: In this study, RNA sequencing of three different P. notoginseng tissues was performed using next generation DNA sequencing. After assembling the high quality sequencing reads into 107,340 unigenes, biochemical pathways were predicted and 9,908 unigenes were assigned to 135 KEGG pathways. Among them, 270 unigenes were identified to be involved in triterpene saponin biosynthesis. In addition, 350 and 342 unigenes were predicted to encode cytochrome P450s and glycosyltransferases, respectively, based on the annotation results, some of which encode enzymes responsible for the conversion of the triterpene saponin backbone into different ginsenosides. In particular, one unigene predominantly expressed in the root was annotated as CYP716A53v2, which probably participates in the formation of protopanaxatriol from protopanaxadiol in P. notoginseng. The differential expression of this gene was further confirmed by real-time PCR. CONCLUSIONS: We have established a global transcriptome dataset for P. notoginseng and provided additional genetic information for further genome-wide research and analyses. Candidate genes involved in ginsenoside biosynthesis, including putative cytochrome P450s and glycosyltransferases were obtained. The transcriptomes in different plant tissues also provide invaluable resources for future study of the differences in physiological processes and secondary metabolites in different parts of P. notoginseng.


Sujet(s)
Alcaloïdes/biosynthèse , Ginsénosides/biosynthèse , Panax notoginseng/métabolisme , Protéines végétales/génétique , Cytochrome P-450 enzyme system/métabolisme , Fleurs/génétique , Fleurs/métabolisme , Analyse de profil d'expression de gènes/méthodes , Glycosyltransferase/métabolisme , Panax notoginseng/génétique , Feuilles de plante/génétique , Feuilles de plante/métabolisme , Protéines végétales/métabolisme , Racines de plante/génétique , Racines de plante/métabolisme , Sapogénines/métabolisme
19.
Chin J Integr Med ; 21(5): 361-8, 2015 May.
Article de Anglais | MEDLINE | ID: mdl-25776841

RÉSUMÉ

OBJECTIVE: To investigate whether I-tetrahydropalmatine (I-THP), an alkaloid mainly present in Corydalis family, could ameliorate early vascular inflammatory responses in atherosclerotic processes. METHODS: Fluorescently labeled monocytes were co-incubated with human umbilical vein endothelial cells (HUVECs), which were pretreated with I-THP and then simulated with tumor necrosis factor (TNF)-α in absence of I-THP to determine if I-THP could reduce thecytokine-induced adhesion of monocytes to HUVECs. Then I-THP were further studied the underlying mechanisms through observing the transcriptional and translational level of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and the nuclear translocation of nuclear factor (NF)-κ B in HUVECs. RESULTS: L-THP could block TNF-α-induced adhesion of monocytes to HUVECs and could significantly inhibited the expression of ICAM-1 and VCAM-1 on cell surface by 31% and 36% at 30 µ mol/L. L-THP pretreatment could also markedly reduce transcriptional and translational level of VCAM-1 as well as mildly reduce the total protein and mRNA expression levels of ICAM-1. Furthermore, I-THP attenuated TNF-α-stimulated NF-κ B nuclear translocation. CONCLUSION: These results provide evidences supporting that I-THP could be a promising compound in the prevention and treatment of the early vascular inflammatory reaction in atherosclerosis by inhibiting monocyte adhesion to vascular endothelial cell through downregulating ICAM-1 and VCAM-1 in vascular endothelial cell based on suppressing NF-κ B.


Sujet(s)
Alcaloïdes de type berbérine/pharmacologie , Régulation négative/effets des médicaments et des substances chimiques , Cellules endothéliales de la veine ombilicale humaine/cytologie , Molécule-1 d'adhérence intercellulaire/métabolisme , Monocytes/cytologie , Facteur de transcription NF-kappa B/métabolisme , Facteur de nécrose tumorale alpha/pharmacologie , Molécule-1 d'adhérence des cellules vasculaires/métabolisme , Adhérence cellulaire/effets des médicaments et des substances chimiques , Noyau de la cellule/effets des médicaments et des substances chimiques , Noyau de la cellule/métabolisme , Cellules endothéliales de la veine ombilicale humaine/effets des médicaments et des substances chimiques , Cellules endothéliales de la veine ombilicale humaine/métabolisme , Humains , Molécule-1 d'adhérence intercellulaire/génétique , Monocytes/effets des médicaments et des substances chimiques , Monocytes/métabolisme , Transport des protéines/effets des médicaments et des substances chimiques , ARN messager/génétique , ARN messager/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Facteur de transcription RelA/métabolisme , Molécule-1 d'adhérence des cellules vasculaires/génétique
20.
Article de Anglais | WPRIM (Pacifique Occidental) | ID: wpr-310838

RÉSUMÉ

<p><b>OBJECTIVE</b>To investigate whether I-tetrahydropalmatine (I-THP), an alkaloid mainly present in Corydalis family, could ameliorate early vascular inflammatory responses in atherosclerotic processes.</p><p><b>METHODS</b>Fluorescently labeled monocytes were co-incubated with human umbilical vein endothelial cells (HUVECs), which were pretreated with I-THP and then simulated with tumor necrosis factor (TNF)-α in absence of I-THP to determine if I-THP could reduce thecytokine-induced adhesion of monocytes to HUVECs. Then I-THP were further studied the underlying mechanisms through observing the transcriptional and translational level of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and the nuclear translocation of nuclear factor (NF)-κ B in HUVECs.</p><p><b>RESULTS</b>L-THP could block TNF-α-induced adhesion of monocytes to HUVECs and could significantly inhibited the expression of ICAM-1 and VCAM-1 on cell surface by 31% and 36% at 30 μ mol/L. L-THP pretreatment could also markedly reduce transcriptional and translational level of VCAM-1 as well as mildly reduce the total protein and mRNA expression levels of ICAM-1. Furthermore, I-THP attenuated TNF-α-stimulated NF-κ B nuclear translocation.</p><p><b>CONCLUSION</b>These results provide evidences supporting that I-THP could be a promising compound in the prevention and treatment of the early vascular inflammatory reaction in atherosclerosis by inhibiting monocyte adhesion to vascular endothelial cell through downregulating ICAM-1 and VCAM-1 in vascular endothelial cell based on suppressing NF-κ B.</p>


Sujet(s)
Humains , Alcaloïdes de type berbérine , Pharmacologie , Adhérence cellulaire , Noyau de la cellule , Métabolisme , Régulation négative , Cellules endothéliales de la veine ombilicale humaine , Biologie cellulaire , Métabolisme , Molécule-1 d'adhérence intercellulaire , Génétique , Métabolisme , Monocytes , Biologie cellulaire , Métabolisme , Facteur de transcription NF-kappa B , Métabolisme , Transport des protéines , ARN messager , Génétique , Métabolisme , Transduction du signal , Facteur de transcription RelA , Métabolisme , Facteur de nécrose tumorale alpha , Pharmacologie , Molécule-1 d'adhérence des cellules vasculaires , Génétique , Métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE